TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,595,000 | +89.1% | 140,801 | -32.5% | 1.23% | +149.6% |
| Q1 2022 | $5,602,000 | -78.6% | 208,630 | -62.0% | 0.49% | -73.7% |
| Q4 2021 | $26,217,000 | -12.9% | 549,626 | +21.4% | 1.88% | -5.3% |
| Q3 2021 | $30,085,000 | -2.6% | 452,878 | +14.4% | 1.98% | +7.0% |
| Q2 2021 | $30,882,000 | +454.5% | 395,825 | +572.3% | 1.85% | +402.2% |
| Q1 2021 | $5,569,000 | -17.9% | 58,879 | +5.7% | 0.37% | -26.5% |
| Q4 2020 | $6,785,000 | +41.6% | 55,681 | +1.5% | 0.50% | +2.2% |
| Q3 2020 | $4,790,000 | -61.5% | 54,833 | -71.6% | 0.49% | -66.2% |
| Q2 2020 | $12,455,000 | – | 192,829 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |